"We've launched the new BioBot 1," reports Danny Cabrera, cofounder of BioBots, the South Philly-based (at Evan Malone's NextFab on Washingotn Ave.) 3-D human-tissue printer.
After winning additional backing from its very-early-stage Philadelphia-based investors DreamIt Ventures and Ben Franklin Technology Partners, Cabrera's group "filled up our Beta program with some of the best researchers across the world" and updated the original $25,000, milk-crate-sized machine, Cabrera tells me.
He's collected testimonials:
-- "In general, this system is very convenient to use, the interface is user-friendly, and the printer works stable," writes Zazao Chen at Columbia U, who adds the lab there has "printed some branched blood vessels and cells," and feels grateful to be a BioBot pioneer.
-- "The instrument is ready for use. The platform is easy to maintain. It is flexible." -- Dayu Teng, UC at San Diego
-- Kara Spiller, a pioneering BioBots user at Drexel who told me last winter that she's saved a fortune over her former roomful of equipment with an earlier BioBot, adds that "its portability lets us bring it to the optimal location to print each tissue type."
























